India's drug regulator is proposing to allow hospitals to directly import advanced medical equipment like MRI and CT scanners, bypassing cu...

Even in small villages with a population of less than 1,000, where certain remedies including cough syrups were allowed to be sold without ...

The Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...

Excise officials in Hyderabad arrested a former software engineer for cultivating cannabis plants on his terrace. Investigators linked the ...

Gurgaon Drug Racket: Authorities in Gurgaon have busted a major illegal pharmaceutical racket involving spurious Mounjaro KwikPen (tirzepat...

Balaji Amines faces accusations from Indian authorities for producing pharma-grade propylene glycol without a necessary drug manufacturing ...

Earlier this year, the Central Drugs Standard Organisation (CDSCO) had set the October 1 deadline for bringing 'class C' and 'class D' medi...

The decision to cancel the licence was taken after the Regional Drugs Testing Laboratory (RDTL), Chandigarh, which tested the samples of th...

Over 70 fixed dose combination (FDC) medicine brands marketed by 16 pharma companies have been seized in an ongoing raid of two drug manufa...

The licences and approvals can be made perpetual provided they are not cancelled or suspended by the licencing authority, according to the ...

The government is planning a major overhaul of the country's drug policy, with moves that include scrapping the need to renew manufacturing...

The move is part of a drive to weed out supplies of substandard drugs in the market, a senior official in the health ministry told ET.

Delhi High Court today sought Centre's response on a plea moved by healthcare major Reckitt Benckiser challenging the state licensing autho...

Drug makers may have to shell out significantly higher fees for a whole set of regulatory submissions in India in the New Year.

A compulsory licence (CL) will allow the government to source generic versions of the patented drug and sell them at a fraction of the cost.

Licences for manufacturing drugs under 17 critical categories will be given only by the Centre and not by states, a new bill has proposed.

The drug controller had earlier directed the state drug controllers to withdraw 294 FDCs which got licences without approval of DCGI.